Investment
Features
FeesSafety
Academy
More
Pluang+

Choice Hotels to announce Q3 2026 earnings on Nov 2 with a live conference call.

Company Fundamentals
07 Oct 2026
PRNewsWire
View Source
Neutral
Choice Hotels to announce Q3 2026 earnings on Nov 2 with a live conference call.

Choice Hotels International will release its third quarter 2026 earnings on November 2, 2026, at 6:30 a.m. ET. The company will hold a conference call at 10:00 a.m. ET the same day, where CEO Dom Dragisich and CFO Scott Oaksmith will discuss the results and answer questions. Investors can join via webcast or phone, with a replay available afterward. This event provides insight into the company's recent performance and outlook.

Choice Hotels International's upcoming Q3 2026 earnings report provides context for market watchers. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 07, 2026 19:01 WIB: out of 112 priced US stocks, 28 rose and 79 fell. Hilton Hotels Corporation was priced at USD 316.19 with a 1-day change of -1.99%, Carparts.Com Inc at USD 8.44 with 100% sell order activity, and Carnival Corp at USD 26.08 with 100% buy order activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
58 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
2 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App